Gynecologic Cancer News

Clinical trials performed within the NCI’s National Clinical Trials Network during the past 40 years prolonged the lives of patients with cancer by at least 14.2 million life-years, according to a study in Journal of Clinical Oncology.

Rachel Pozzar, PhD, RN, received Oncology Nursing Society’s Victoria Mock New Investigator Award.

Clinicians should advocate for opportunistic salpingectomy among patients undergoing surgery for benign pelvic diseases to prevent ovarian cancer, according to a consensus statement from the Ovarian Cancer Research Alliance.

The FDA granted regular approval to dostarlimab-gxly for treatment of certain women with endometrial cancer.

Longer duration of ovulation across the life span was associated with a greater risk for epithelial ovarian cancer, according to data published in the Journal of the National Cancer Institute.

Up to 8 months before diagnosis, women with ovarian cancer purchased more over-the-counter pain and indigestion medications vs. women without ovarian cancer, according to findings of an observational case-control study.

Researchers at Cold Spring Harbor Laboratory have developed software that correctly deduces continental ancestry from tumor DNA and RNA.

The addition of pembrolizumab to chemotherapy significantly extended PFS as first-line treatment for advanced or recurrent endometrial carcinoma, according to the agent’s manufacturer.

Young survivors of pediatric cancers are at increased risk for a host of short-term and late health conditions, including HPV-related malignancies such as cervical and oropharyngeal cancers.

Presence of certain bacteria in the microbiome may indicate early-stage ovarian cancer, according to data published in Scientific Reports.